Hepatitis C Nucleic Acid Test Positive (NAT+) Solid Organ Consent Rates Are Highest in Patients Listed for Liver Transplant and With an English Language Preference
Clinical Transplantation · 2025
DOI: 10.1111/ctr.70186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Transplantation, 2025. Verfasst von Sachiko M Oshima und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Medicine, Duke University Health System, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Hepacivirus, Liver Transplantation, Waiting Lists, Hepatitis C. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMHD NIH HHS, Duke Division of Gastroenterology Dawn Provenzale Award, Duke Department of Medicine Stead Resident Research Grant.
Abstract (Originalsprache)
Background
Transplantation of hepatitis C virus (HCV) nucleic acid (NAT) positive organs is associated with shorter time to transplant and decreased risk of death on the waiting list. Treatment for HCV post‐transplant is well‐tolerated, successful, and leads to similar transplant outcomes to patients transplanted with HCV NAT− organs. Despite these outcomes, not all patients consent to receive HCV NAT+ organs, and factors associated with consent are not well‐known.
Methods
This retrospective single‐center study of adult patients listed for heart, liver, lung, and kidney transplant aimed to determine whether sociodemographic and organ‐specific disparities exist in consent for HCV NAT+ donor organs.
Results
Of 2788 transplant candidates, 44% ( N = 1229) consented to receive an HCV NAT+ organ. Patients who designated English as their preferred language were more likely to consent compared to a non‐English preference (45% vs. 19%, p < 0.001). Consent rates were highest amongst patients listed for liver transplantation compared to kidney, heart, and lung transplants (67%, N = 319 vs. 42%, N = 602 vs. 38%, N = 159 vs. 32%, N = 149; p < 0.001).
Conclusions
Overall, more efforts are needed to ensure that all patients who may benefit from consenting for HCV NAT+ organs are appropriately educated in their language of choice on the risks and benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Medicine, Duke University Health System, Durham, North Carolina, USA.
- Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina, USA.
- Department of Surgery, Duke University Health System, Durham, North Carolina, USA.
ORCID-Profile: Sachiko M Oshima, Alice Parish, Jacqueline B Henson, Mariya Samoylova, Donna Niedzwiecki, Lisa McElroy, Lindsay King, Julius M Wilder, Kara Wegermann
Förderung
- NIMHD NIH HHS
- Duke Division of Gastroenterology Dawn Provenzale Award
- Duke Department of Medicine Stead Resident Research Grant
Zitieren
APA
Oshima, S. M., Parish, A., Henson, J. B., Samoylova, M., Niedzwiecki, D., McElroy, L., King, L., Wilder, J. M., & Wegermann, K. (2025). Hepatitis C Nucleic Acid Test Positive (NAT+) Solid Organ Consent Rates Are Highest in Patients Listed for Liver Transplant and With an English Language Preference. Clinical Transplantation. https://doi.org/10.1111/ctr.70186
Vancouver
Oshima SM, Parish A, Henson JB, Samoylova M, Niedzwiecki D, McElroy L, et al. Hepatitis C Nucleic Acid Test Positive (NAT+) Solid Organ Consent Rates Are Highest in Patients Listed for Liver Transplant and With an English Language Preference. Clinical Transplantation. 2025. doi:10.1111/ctr.70186
BibTeX
@article{Oshima2025,
author = {Oshima, Sachiko M and Parish, Alice and Henson, Jacqueline B and Samoylova, Mariya and Niedzwiecki, Donna and McElroy, Lisa and King, Lindsay and Wilder, Julius M and Wegermann, Kara},
title = {Hepatitis C Nucleic Acid Test Positive (NAT+) Solid Organ Consent Rates Are Highest in Patients Listed for Liver Transplant and With an English Language Preference},
journal = {Clinical Transplantation},
year = {2025},
doi = {10.1111/ctr.70186}
}
EUVIMED